BRA/ Mek Treatment holiday flops in la... - Melanoma Caregivers

Melanoma Caregivers

BRA/ Mek Treatment holiday flops in late stage melanoma trial

missyrand profile image
missyrandAmbassador
0 Replies

medpagetoday.com/meetingcov...

This is an important finding. Note that the study size is around 200, but the outcome was consistent across age and gender for those with advanced melanoma.

For patients with advanced BRAF-mutant melanoma, taking a treatment holiday from BRAF/MEK inhibitors (with the goal of forestalling drug resistance instead led to earlier disease progression, a randomized trial found.

In the phase II study of over 200 patients, median progression-free survival (PFS) for those receiving intermittent dosing of dabrafenib (Tafinlar) and trametinib (Mekinist) was 5.5 months, as compared to 9.0 months for patients receiving continuous treatment (HR 1.36, 80% CI 1.10-1.66, P=0.063), reported Alain Algazi, MD, of the University of California San Francisco.

Peace,

Missy

Written by
missyrand profile image
missyrand
Ambassador
To view profiles and participate in discussions please or .
Read more about...

Not what you're looking for?

You may also like...

Treatment and monitoring for children with stage 3 melanoma

I am a mother of a 13 year old boy diagnosed with stage 3 b melanoma just over one year ago. I...

New member — husband stage IV melanoma

Hi All - my 40 yr old husband, who had a melanoma removed from his chest a few years prior and had...

Husband - Jim stage 4 melanoma (how he got in remission)

Hi everyone my name is Christina in New York and I would like to share with you the story of my...

New to the group

My son was diagnosed with stage 4 melanoma at the age of 22 in 2015. He had a big lump on the back...

Melanoma radiation for shoulder planned

Update: Today is a full body Pet scan again for my husband who has Stage 4a metastatic melanoma....